Oksana(Olyva)HamidiDOMSCS
Endocrinology • Dallas, TXAdrenal Disease, Pituitary Disorders & Neuroendocrinology
Associate Professor
Dr. Hamidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-2800Fax+1 214-645-2808
Summary
- Dr. Oksana Hamidi is an endocrinologist in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. She received her medical degree from Chicago College of Osteopathic Medicine and has been in practice 5 years. She specializes in adrenal disease, diabetes, lipid metabolism, and pituitary disorders & neuroendocrinology and is experienced in pituitary disease, adrenal disease, and neuroendocrinology.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2018
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2012 - 2015
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2012
Certifications & Licensure
TX State License 2018 - 2026
MN State License 2015 - 2018
IL State License 2012 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Clinical and radiological features of atypical adrenal masses- a multicenter retrospective study.Vania Balderrama-Brondani, Ruaa Al-Ward, Katja Kiseljak-Vassiliades, Lauren Fishbein, Danielle Dawes
The Journal of Clinical Endocrinology and Metabolism. 2024-11-06 - Clinical Review: The Approach to the Evaluation and Management of Bilateral Adrenal Masses.Ann T Sweeney, Oksana Hamidi, Prerna Dogra, Shobana Athimulam, Ricardo Correa
Endocrine Practice. 2024-10-01 - Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases.Oksana Hamidi, Mihailo Miljanic, Gayane Tumyan, Alana Christie, Sasan Mirfakhraee
Cancers. 2024-09-12
Press Mentions
Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024May 10th, 2024- CAH Treatment 'Struggle' Points to Unmet NeedMay 16th, 2024
- UTSW Research: Female Sex Hormones, Adrenal Hyperplasia, and MoreJuly 3rd, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
